+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hepatitis Test Solution/Diagnosis Market Research Report by Technology, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5122834
  • Report
  • September 2021
  • Region: United States
  • 87 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Hepatitis Test Solution/Diagnosis Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Hepatitis Test Solution/Diagnosis Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Hepatitis Test Solution/Diagnosis to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the Hepatitis Test Solution/Diagnosis Market was studied across Enzyme-linked Immunosorbent Assay (ELISA), Isothermal Nucleic Acid Amplification Technology (INAAT), Polymerase Chain Reaction (PCR), and Rapid Diagnostic Tests (RDT).
  • Based on Disease Type, the Hepatitis Test Solution/Diagnosis Market was studied across Hepatitis B (HBV) and Hepatitis C (HCV).
  • Based on State, the Hepatitis Test Solution/Diagnosis Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hepatitis Test Solution/Diagnosis Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Hepatitis Test Solution/Diagnosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Hepatitis Test Solution/Diagnosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Hepatitis Test Solution/Diagnosis Market?
4. What is the competitive strategic window for opportunities in the United States Hepatitis Test Solution/Diagnosis Market?
5. What are the technology trends and regulatory frameworks in the United States Hepatitis Test Solution/Diagnosis Market?
6. What is the market share of the leading vendors in the United States Hepatitis Test Solution/Diagnosis Market?
7. What modes and strategic moves are considered suitable for entering the United States Hepatitis Test Solution/Diagnosis Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Disease Type Outlook
3.5. State Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Hepatitis Test Solution/Diagnosis Market, by Technology
6.1. Introduction
6.2. Enzyme-linked Immunosorbent Assay (ELISA)
6.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4. Polymerase Chain Reaction (PCR)
6.5. Rapid Diagnostic Tests (RDT)

7. Hepatitis Test Solution/Diagnosis Market, by Disease Type
7.1. Introduction
7.2. Hepatitis B (HBV)
7.3. Hepatitis C (HCV)

8. California Hepatitis Test Solution/Diagnosis Market
8.1. Introduction

9. Florida Hepatitis Test Solution/Diagnosis Market
9.1. Introduction

10. Illinois Hepatitis Test Solution/Diagnosis Market
10.1. Introduction

11. New York Hepatitis Test Solution/Diagnosis Market
11.1. Introduction

12. Ohio Hepatitis Test Solution/Diagnosis Market
12.1. Introduction

13. Pennsylvania Hepatitis Test Solution/Diagnosis Market
13.1. Introduction

14. Texas Hepatitis Test Solution/Diagnosis Market
14.1. Introduction

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 3. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
FIGURE 4. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 5. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MARKET DYNAMICS
FIGURE 7. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 8. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 10. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), 2018-2026 (USD MILLION)
FIGURE 11. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 12. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
FIGURE 19. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2026
FIGURE 21. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. CALIFORNIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. FLORIDA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. ILLINOIS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. NEW YORK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. OHIO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. PENNSYLVANIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. TEXAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: FPNV POSITIONING MATRIX
FIGURE 33. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 34. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), BY STATE, 2018-2026 (USD MILLION)
TABLE 12. CALIFORNIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. FLORIDA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. ILLINOIS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. NEW YORK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. OHIO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. PENNSYLVANIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. TEXAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SCORES
TABLE 20. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: BUSINESS STRATEGY
TABLE 21. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: PRODUCT SATISFACTION
TABLE 22. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RANKING
TABLE 23. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 24. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll